Latest news: The clinical research results of the intelligent rehabilitation robot developed by Angelexo Scientific have been published in the international journal Frontiers

Recently, an academic study on the clinical application of the LiteStepper® Unilateral Lower Limb Hemiplegic Exoskeleton, independently developed by Angelexo Scientific, titled 'Efficacy and Safety of Using a Unilateral Lower Limb Exoskeleton Combined with Conventional Treatment in Post-Stroke Rehabilitation: A Randomized Controlled Trial,' was published in the international journal Frontiers in Bioengineering and Biotechnology.

This multi-center randomized controlled trial, conducted in the convalescent rehabilitation ward of four hospital, involved 92 participants in their post-stroke phase. Participants were randomized into an experimental group (EG) or a conventional group (CG). The EG adopted the LiteStepper® ULLE combined with conventional treatment for 21 days. The CG underwent a standard daily rehabilitation routine for 21 days. The findings demonstrate both efficacy and safety regarding the clinical application of LiteStepper® for hemiplegic rehabilitation while further confirming its feasibility and value when combined with traditional stroke rehabilitation therapies.

Assessment tools employed included BBS (Berg Balance Scale), FAC (Functional Ambulation Classification), 6 MWT (6-Minute Walk Test), and Barthel Index—all aimed at comprehensively evaluating balance capabilities alongside mobility independence pre- & post-rehabilitation sessions respectively yielding significant improvements noted particularly on day fourteen & twenty-one where evaluators recorded markedly higher BBS scores within EG compared against CG—with greater overall enhancements observed additionally reflected across FAC metrics as well as both Barthel index evaluations too!

To summarize succinctly—the integration between LiteStepper® ULLE therapy coupled together harmoniously alongside conventional methods demonstrates pronounced advantages enhancing balance functionality whilst improving ambulation skills plus fostering ADL independence amongst individuals recovering from strokes exhibiting signs/symptoms associated specifically related towards their respective conditions! Furthermore—it showcases high levels concerning safety thereby providing novel efficacious means facilitating successful recoveries ultimately holding substantial implications clinically speaking!